Biofrontera (BFRI) Income from Continuing Operations (2020 - 2025)
Historic Income from Continuing Operations for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$6.6 million.
- Biofrontera's Income from Continuing Operations fell 1728.7% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 3688.56%. This contributed to the annual value of -$17.8 million for FY2024, which is 1178.28% up from last year.
- Latest data reveals that Biofrontera reported Income from Continuing Operations of -$6.6 million as of Q3 2025, which was down 1728.7% from -$5.3 million recorded in Q2 2025.
- In the past 5 years, Biofrontera's Income from Continuing Operations ranged from a high of $5.6 million in Q1 2022 and a low of -$16.0 million during Q3 2021
- For the 5-year period, Biofrontera's Income from Continuing Operations averaged around -$4.9 million, with its median value being -$4.2 million (2025).
- In the last 5 years, Biofrontera's Income from Continuing Operations soared by 25735.71% in 2022 and then tumbled by 197159.53% in 2025.
- Over the past 5 years, Biofrontera's Income from Continuing Operations (Quarter) stood at -$14.5 million in 2021, then surged by 80.8% to -$2.8 million in 2022, then soared by 226.61% to $3.5 million in 2023, then crashed by 139.59% to -$1.4 million in 2024, then crashed by 376.29% to -$6.6 million in 2025.
- Its last three reported values are -$6.6 million in Q3 2025, -$5.3 million for Q2 2025, and -$4.2 million during Q1 2025.